Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable locally advanced esophageal squamous cell carcinoma

被引:0
|
作者
Yoshinami, Y. [1 ]
Yamamoto, S. [1 ]
Shiraishi, K. [1 ]
Itoyama, M. [1 ]
Imazeki, H. [1 ]
Yokoyama, K. [1 ]
Honma, Y. [1 ]
Kurita, D. [2 ]
Ishiyama, K. [2 ]
Oguma, J. [2 ]
Daiko, H. [2 ]
Kato, K. [1 ]
机构
[1] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan
关键词
D O I
10.1016/j.annonc.2024.05.329
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
415P
引用
收藏
页码:S168 / S168
页数:1
相关论文
共 50 条
  • [31] Are more courses of immunochemotherapy beneficial for the short-term outcome of locally advanced esophageal squamous cell carcinoma?
    Huang, Yuanheng
    Su, Xiaodong
    Guo, Qiyu
    Luo, Guangyu
    He, Haoqiang
    Cai, Peiqiang
    Cai, Muyan
    Yue, Haodong
    Wang, Zhiqiang
    Yang, Guozhen
    Lin, Peng
    Zhang, Xu
    THORACIC CANCER, 2023, 14 (13) : 1153 - 1161
  • [32] Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas
    Wang, Kai
    Gui, Lin
    Lu, Haizhen
    He, Xiaohui
    Li, Dezhi
    Liu, Chang
    Liu, Shaoyan
    Wang, Xiaolei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas
    Wang, K.
    Gui, L.
    Lu, H.
    He, X.
    Li, D.
    Liu, C.
    Liu, S.
    Wang, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S572 - S572
  • [34] The efficacy and safety of neoadjuvant sintilimab combined with chemotherapy in resectable locally advanced lymph node-positive esophageal squamous cell carcinoma: A real world study
    Ye, Peng
    Rusidanmu, Aizemaiti
    Lin, Shuang
    Zhou, Kun
    Wu, Xuhui
    Huang, Bin
    Wu, Gongzhi
    Peng, Congxiong
    Peng, Xuyang
    Ding, Jianyang
    Huang, Mingjiang
    Yu, Huanming
    Zhi, Shengxu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma
    Huang, Yuan-Heng
    Yang, Guo-Zhen
    Chen, Hui-Guo
    Li, Xiao-Jun
    Wu, Yong-Hui
    Zhang, Kai
    Xu, Jian-Nan
    Zhang, Jian
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (09)
  • [36] Neoadjuvant versus adjuvant treatment: Which one is better for resectable locally advanced esophageal squamous cell carcinoma?
    Chen, Qixun
    Xu, Yaping
    Zheng, Yuanda
    Yu, Xinmin
    Lin, Qingren
    Jiang, Youhua
    Zhou, Xinming
    Mao, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial
    Jun Yin
    Jingnan Yuan
    Yunjin Li
    Yong Fang
    Ruoxi Wang
    Heng Jiao
    Han Tang
    Shaoyuan Zhang
    Siyun Lin
    Feng Su
    Jianmin Gu
    Tian Jiang
    Dong Lin
    Zhiliang Huang
    Chaoxiang Du
    Kui Wu
    Lijie Tan
    Qing Zhou
    Nature Medicine, 2023, 29 : 2068 - 2078
  • [38] A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Yang, Yalan
    Xin, Dao
    Wang, Huike
    Guan, Lulu
    Meng, Xiangrui
    Lu, Taiying
    Bai, Xiwen
    Wang, Feng
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1443 - 1455
  • [39] Neoadjuvant adebrelimab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: A phase 2 trial
    Li, Zhigang
    Yang, Yang
    Liu, Zhichao
    Li, Chunguang
    Su, Yuchen
    Zhang, Hong
    Liu, Jun
    Zhang, Ming
    Dong, Yun
    Han, Yuchen
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 443 - 443
  • [40] Comparison of efficacy and safety of neoadjuvant regimens for resectable esophageal squamous cell carcinoma: A meta-analysis
    Wang, Ting
    Cai, Liyu
    Guo, Zefeng
    You, Peimeng
    Liu, Shengbo
    Qiu, Hongrui
    Li, Hao
    Wu, Shaowei
    Zhou, Haiyu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)